What You Should Know:
- A new report from Soliant Health reveals a concerning trend: healthcare professionals across all age groups are leaving the industry due to job stress, poor work-life balance, and unhealthy workplace cultures.
- Surprisingly, Gen Z (ages 18-27) is leading the exodus, with over 22% planning to leave their healthcare jobs within the next 1-3 years.
Generational Differences in Departure Drivers
While all generations struggle with workplace challenges,
Read More
Ransomware Attacks on Healthcare Services Surge in 2024
What You Should Know:
- Ransomware attacks are a growing threat across all industries, but the healthcare sector is facing a particularly alarming surge in these incidents, according to new data from SafetyDevices.
- New data reveals a concerning trend of increased attacks on healthcare providers, raising concerns about patient safety, data security, and the financial stability of healthcare organizations.
Healthcare: A Prime Target for Cybercriminals
Healthcare services are
Read More
Impilo Secures $11.5M to Expand Access to At-Home Healthcare
What You Should Know:
- Impilo, a digital health platform revolutionizing healthcare access raises $11.5M in a Series A funding round led by Construct Capital, with participation from GC 1 Capital, One Way Ventures, 2048 Ventures, and strategic angel investors.
- Impilo's vision is a world where access to world-class healthcare is no longer limited by location or circumstance. By leveraging technology and innovation, Impilo is making this vision a reality, bringing convenient,
Read More
Navigating the Complexities of Preclinical and Clinical Trials
The development of new drugs or medical interventions is a meticulous process involving various stages to ensure safety, efficacy, and regulatory compliance. Central to this journey are the preclinical and clinical trial phases, which are vital for transitioning from laboratory research to clinical application. Let us take a look at the whole process – step by step.
Preclinical Studies: Laying the Groundwork
The preclinical phase involves extensive in vitro (test tube or cell culture) and
Read More
Q/A: Funding Landscape: IPO or Buyout for Life Science Companies?
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth, or is a strategic buyout from a larger company a more suitable path?
In this exclusive interview, Taylor Wirth, a partner at Barnes & Thornburg, offers his insights on evaluating market conditions, assessing company readiness, and weighing the pros and cons of each funding option. He
Read More
Primary Care Provider Forward Closes Its Doors
What You Should Know:
- Forward, a technology-driven preventive primary care provider, has announced the immediate closure of all its locations and the shutdown of its mobile app.
- The sudden announcement leaves members scrambling to find new providers and access their medical records.
Immediate Cessation of Services
Effective immediately, Forward has ceased all operations, including:
Employee Layoffs: All 200 Forward employees will be laid off. Closure of
Read More
Healthpilot and Publix Partner to Simplify Medicare Plan Selection for Seniors
What You Should Know:
- Healthpilot, an AI-powered Medicare comparison platform, and Publix Supermarkets have joined forces to simplify the process of choosing Medicare plans for seniors.
- Publix Pharmacy customers can now access Healthpilot's comparison tool directly through the Publix website to review and compare Medicare Advantage and Part D prescription drug plans where Publix Pharmacy is a preferred pharmacy and Healthpilot is affiliated.
Addressing the Complexity of
Read More
Medeloop Raises $15.5M for AI-Driven Medical Research Platform
What You Should Know:
- Medeloop, a pioneering medical research platform, has secured $15.5M in Series A funding to further its mission of revolutionizing medical research through artificial intelligence (AI).
- The funding round was led by Inovia Capital, with participation from Icon Ventures and support from existing investors General Catalyst and Maven Ventures.
AI-Powered Platform Streamlines Research
Founded by AI experts at Stanford, Medeloop partners with
Read More
Bluespine Raises $7.2M to Combat Medical Overbilling with AI
What You Should Know:
- Bluespine, an AI-driven claims cost reduction platform for self-insured employers, has secured $7.2M in seed funding to address the pervasive issue of medical overbilling in the US healthcare system led by Team8.
- The seed funding will accelerate Bluespine's adoption by US employers and brokers, as well as support further research and development.
Tackling the Healthcare Cost Crisis
Bluespine was co-founded by a team of technology experts with deep
Read More
Q/A: Medidata VP Talks Overcoming Financial Barriers to Diversity in Clinical Trials
Achieving diversity in clinical trials is crucial for developing effective and safe treatments for all populations. Yet, financial barriers often exclude underrepresented groups from participating, hindering progress towards health equity. This disparity raises critical questions about the accessibility and inclusivity of medical research.
In this insightful Q&A, Meghan Harrington, VP of Clinical Trial Financial Management at Medidata, a Dassault Systèmes brand, sheds light on the
Read More
